No Detail Found!

Comparison of Efficacy of Chloroquine and Artemether/lumafantrine in Treating Vivax Malaria in Thall and Surrounding Area.

Author(s)
Syed Mohammad Abrar Department of Medicine, Ayub Teaching Hospital, Abbottabad, Pakistan
Syed Sajid Ali Shah Department of Paediatrics, Combined Military Hospital, Quetta-Pakistan
Raja Jibran Akbar Department of Medicine, Ayub Teaching Hospital, Abbottabad, Pakistan
Sheema Rahim Department of Obstetrics & Gynaecology, Ayub Teaching Hospital, Abbottabad, Pakistan
Faizan Malik Department of Medicine, Ayub Teaching Hospital, Abbottabad, Pakistan
Fakhar Uzzaman Khan Department of Medicine, Ayub Teaching Hospital, Abbottabad, Pakistan
Abstract
Background: Fever is the main complaint in patients reporting to our hospital and the most common cause of fever in our set up is malaria. The aim of this study was to know about the clinical response, efficacy and resistance of vivax malaria to chloroquine in patients reporting to Thall Scouts Hospital. Methods: All the adult male patients reporting to Thall Scouts Hospital with fever and other symptoms of malaria having slide positive vivax malaria were included in the study. Both thick and thin slide were used for the diagnosis and species determination of malaria. Age group of the patients was from 18-40 years old. The study was conducted for the period of two years. Results: Total number of patients included in the study was 518. Of the 518 patients, 374 (72.2%) responded to chloroquine and the remaining 144 (27.8%) were given Arthemether/Lumafantrine combination. Having positive symptoms of malaria total 374 patients treated with chloroquine 171 (45.72%) were asymptomatic after 24 hours, 98 (26.2%) after 48 hours, 78 (20.86%), after 72 hours of treatment while 27 (7.22%) were found to be resistant to chloroquine. Of the 144 patients having positive malaria treated with Artemether/Lumafantrine 62 (43.06%) were asymptomatic after 24 hours, 65 (45.14%) after 48 hours, 13 (9.03%) after 72 hours while 4 (2.78%) had still positive symptoms of malaria. Conclusion: Vivax malaria in our set up is sensitive to both Chloroquine and Arthemether/Lumafantrine. As Chloroquine is a cheap and easily available drug, so it can be safely given to patients with vivax malaria. It will also decrease the total cost of the disease.
Publication Details
Page(s) 574-576
DOI DOI not available
Published Journal: Journal of Ayub Medical College, Volume: 29, Issue: 4, Year: 2017

Request the full text from PASTIC

References
,2013,,World malaria report 2012,,,
DMC,,2013,Malaria No More,Islamabad: Directorate of Malaria Control,,,
MostH,LondonIM,KaneCA,LavietesPH,SchroderEF,HaymanJM,,1946,Chloroquine for the treatment of acute attacks of vivax malaria,J Am Med Assoc,131,963,7
RieckmanKH,DavisDR,HuttonDC,,1989,,? Lancet,2,1183,4
SumawinataIW,LeksanaB,SutamihardjaA,SubiantoB,FryauffDJ,BairdJK,,2003,Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparumandP.vivaxmalaria in Indonesian Papua,Am J Trop Med Hyg,68,416,20
GuthmannJP,PittetA,LesageA,ImwongM,LindegardhN,Min LwinM,,2008,Plasmodium vivax resistance to chloroquine in Dawei, Southern Myanmar,Trop Med Int Health,13,91,8
,2009,Prevalence of antimalarial drug resistance mutations inPlasmodium vivaxandP. falciparum from a malariaendemic area of Pakistan,Am J Trop Med Hyg,81,525,8
GhanchiNK,UrsingJ,BegMA,VeigaMI,JafriS,MartenssonA,,2011,Prevalence of resistance associated polymorphisms inPlasmodium falciparumfield isolates from southern Pakistan,Malar J,10,18,
LeslieT,MayanMI,HasanMA,SafiMH,KlinkenbergE,WhittyCJ,,2007,Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial,JAMA,297,2201,9
,2009,,World Malaria Report 2008,,,
McCombieSC,,2002,Self-treatment for malaria: the evidence and methodological issues,Health Policy Plan,17,333,44
PagnoniF,ConvelboN,TiendrebeogoJ,CousensS,EspositoF.,,1997,A community-based programme to provide promt and adequate treatment of presumptive malaria in children,Trans R Soc Trop Med Hyg,91,512,7
KidaneG,MorrowRH,,2000,Teaching mothers to provide home treatment of malaria in Tigray, Ethiopia: a randomised trial,Lancet,356,550,5
MüllerO,YéM,LouisVR,SiéA,,2009,Malaria in sub-Saharan Africa,Lancet,373,122,
PhanGT,de VriesPJ,TranBQ,LeHQ,NguyenNV,NguyenTV,,2002,Artemisinin or chloroquine for blood stagePlasmodium vivaxmalaria in Vietnam,Trop Med Int Health,7,858,64
KurcerMA,SimsekZ,KurcerZ.,,2006,The decreasing efficacy of chloroquine in the treatment ofPlasmodium vivaxmalaria,Turkey. Ann Trop Med Parasitol,100,109,13
SotoJ,ToledoJ,GutierrezP,LuzzM,LlinasN,CedenoN,,2001,Plasmodium vivaxclinically resistant to chloroquine in Colombia,Am J Trop Med Hyg,65,90,3
AwabGR,PukrittayakameeS,ImwongM,DondorpAM,WoodrowCJ,LeeSJ,,2010,Dihydroartemisinin-piperaquine versus chloroquine to treatvivaxmalaria in Afghanistan: an open randomized, non-inferiority, trial,Malar J,9,105,
NandyA,AddyM,MajiAK,BandyopadhyayAK,,2003,Monitoring the chloroquine sensitivity ofPlasmodium vivaxfrom Calcutta,Ann Trop Med Parasitol,97,215,20
ValechaN,JoshiH,EapenA,RavinderanJ,KumarA,PrajapatiSK,,2006,Therapeutic efficacy of chloroquine inPlasmodium vivaxfrom areaswith different epidemiological patterns in India and their Pvdhfr gene mutation pattern,Trans R Soc Trop Med Hyg,100,831,7
VijaykadgaS,AlkerAP,SatimaiW,MacArthurJR,MeshnickSR,WongsrichanalaiC,,2012,Delayed Plasmodium falciparum clearance following artesunate-mefloquine combination therapy in Thailand,,Malar J,11,296,
KetemaT,BachaK,BirhanuT,PetrosB,,2009,Chloroquineresistant Plasmodium vivax malaria in Serbo town, Jimma zone, south-west Ethiopia,Malar J,8,177,
DjimdeAA,DoumboOK,TraoreO,GuindoAB,KayentaoK,DiourteY,,2003,Clearance of drug-resistant parasites as a model for protective immunity inP. falciparum malaria,Am J Trop Med Hyg,69,558,63
0

Citations

0

Downloads

45

Views